Cargando…
Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors
Receptors for the peptide hormones glucagon-like peptide-1 (GLP-1R), glucose-dependent insulinotropic polypeptide (GIPR), and glucagon (GCGR) are important regulators of insulin secretion and energy metabolism. GLP-1R agonists have been successfully deployed for the treatment of type 2 diabetes, but...
Autores principales: | Jones, Ben, McGlone, Emma Rose, Fang, Zijian, Pickford, Phil, Corrêa, Ivan R., Oishi, Atsuro, Jockers, Ralf, Inoue, Asuka, Kumar, Sunil, Görlitz, Frederik, Dunsby, Chris, French, Paul M.W., Rutter, Guy A., Tan, Tricia, Tomas, Alejandra, Bloom, Stephen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948418/ https://www.ncbi.nlm.nih.gov/pubmed/33268378 http://dx.doi.org/10.1074/jbc.RA120.016334 |
Ejemplares similares
-
Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling
por: McGlone, Emma Rose, et al.
Publicado: (2021) -
Role of cAMP in Double Switch of Glucagon Secretion
por: Zmazek, Jan, et al.
Publicado: (2021) -
Tail engagement of arrestin at the glucagon receptor
por: Chen, Kun, et al.
Publicado: (2023) -
Hepatocyte cholesterol content modulates glucagon receptor signalling
por: McGlone, Emma Rose, et al.
Publicado: (2022) -
RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling
por: Cegla, Jaimini, et al.
Publicado: (2017)